<?xml version="1.0" encoding="UTF-8"?>
<fig id="vaccines-08-00197-f005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <p>Cross-reactivity of the recombinant vaccine candidates against group 1 hemagglutinins. Breadth of the antibody response elicited by the immunization of BALB/c mice (
   <italic>n</italic> = 6) with the vaccine prototypes was determined by ELISA against a panel of full-length recombinant HA proteins: (
   <bold>A</bold>) cH6/1—head domain from H6N1 A/mallard/Sweden/81/2002 virus and stalk domain from H1N1 A/California/04/2009 virus; (
   <bold>B</bold>) H1N1 A/Solomon islands/03/2006; (
   <bold>C</bold>) H2N2 A/Japan/305/1957; (
   <bold>D</bold>) H5N1 A/Indonesia/5/2005; (
   <bold>E</bold>) H6N4 A/mallard/Sweden/81/2002; (
   <bold>F</bold>) H8N4 A/mallard/Sweden/24/2002; (
   <bold>G</bold>) H9N2 A/guinea fowl/Hong Kong/WF10/1999; (
   <bold>H</bold>) H11N9 A/shoveler/Netherlands/18/1999. The dotted line indicates the limit of antibody detection; error bars represent mean ± SD. Statistical analysis was performed using one-way ANOVA followed by a Tukey’s multiple comparison test (* 
   <italic>p</italic> &lt; 0.05; ** 
   <italic>p</italic> &lt; 0.01; *** 
   <italic>p</italic> &lt; 0.001; **** 
   <italic>p</italic> &lt; 0.0001).
  </p>
 </caption>
 <graphic xlink:href="vaccines-08-00197-g005" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
